Response to 'comment on rigorous benchmarking of T cell receptor repertoire profiling methods for cancer RNA sequencing' by Davydov A.N.; Bolotin D.A.; Poslavsky S. V. and Chudakov D.M

Brief Bioinform. 2023 Sep 22;24(6):bbad355. doi: 10.1093/bib/bbad355.

Authors

Yu-Ning Huang¹, Mohammad Vahed¹, Kerui Peng¹, Houda Alachkar¹, Serghei Mangul^{1

2}

Affiliations

¹ Titus Family Department of Clinical Pharmacy, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, California, 90089, USA.
² Department of Quantitative and Computational Biology, Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, CA 90033, USA.

No abstract available

Keywords: Benchmarking; Immunogenomics; RNA sequencing; T-cell receptor; TCR sequencing.

Publication types

Comment

MeSH terms

Benchmarking*
Humans
Neoplasms* / genetics
Receptors, Antigen, T-Cell, alpha-beta / genetics
Sequence Analysis, RNA
T-Lymphocytes

Substances

Receptors, Antigen, T-Cell, alpha-beta

Grants and funding

R01 CA248381/CA/NCI NIH HHS/United States